MLchartDataset catalogue

ARA-C

Term · Oncology and biomedicine · MLC-T-ONC-000700

A drug used with other drugs to treat adults and children with acute myeloid leukemia and to prevent and treat a type of leukemia that has spread to the meninges (the tissue that covers and protects the brain and spinal cord). It may also be used to treat acute lymphoblastic leukemia and blastic phase chronic myelogenous leukemia. It is also being studied in the treatment of other types of cancer. ARA-C stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite. Also called cytarabine.

Table 1. Record
IdentifierMLC-T-ONC-000700
FieldOncology and biomedicine
Expansionscytarabine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000700",
  "term": "ARA-C",
  "field": "Oncology and biomedicine",
  "definition": "A drug used with other drugs to treat adults and children with acute myeloid leukemia and to prevent and treat a type of leukemia that has spread to the meninges (the tissue that covers and protects the brain and spinal cord). It may also be used to treat acute lymphoblastic leukemia and blastic phase chronic myelogenous leukemia. It is also being studied in the treatment of other types of cancer. ARA-C stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite. Also called cytarabine.",
  "expansions": [
    "cytarabine"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/ara-c/"
}

Record 2,408 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.